Haryana on Friday began human trials of a home-grown vaccine for Covid-19 on three volunteers, who were administered their first dose at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak, reports Sat Singh. O P Kalra, vice-chancellor of the University of Health Sciences, of which PGIMS is a part, said that the trial of covaxin, developed by Hyderabad-based Bharat Biotech, has started in 12 health institutes, including PGIMS-Rohtak and AIIMS, Delhi.
The volunteers, aged between 30 and 55 years, have showed no adverse effects during the three-hour observation period, Kalra added. He added that the second dose will be administered after two weeks. Haryana health and home minister Anil Vij tweeted: “Human trial with Corona vaccine (covaxin) of Bharat Biotech started at PGI Rohtak today. Three subjects were enrolled today. All have tolerated the vaccine very well.”